<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36591237</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>1076724</StartPage><MedlinePgn>1076724</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1076724</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1076724</ELocationID><Abstract><AbstractText Label="BACKGROUND">Low-density granulocytes (LDGs) are a distinct subset of neutrophils whose increased abundance is associated with the severity of COVID-19. However, the long-term effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on LDG levels and phenotypic alteration remain unexplored.</AbstractText><AbstractText Label="METHODS">Using participants na&#xef;ve to SARS-CoV-2 (NP), infected with SARS-CoV-2 with no residual symptoms (NRS), and infected with SARS-CoV-2 with chronic pulmonary symptoms (PPASC), we compared LDG levels and their phenotype by measuring the expression of markers for activation, maturation, and neutrophil extracellular trap (NET) formation using flow cytometry.</AbstractText><AbstractText Label="RESULTS">The number of LDGs was elevated in PPASC compared to NP. Individuals infected with SARS-CoV-2 (NRS and PPASC) demonstrated increased CD10<sup>+</sup> and CD16<sup>hi</sup> subset counts of LDGs compared to NP group. Further characterization of LDGs demonstrated that LDGs from COVID-19 convalescents (PPASC and NRS) displayed increased markers of NET forming ability and aggregation with platelets compared to LDGs from NP, but no differences were observed between PPASC and NRS.</AbstractText><AbstractText Label="CONCLUSIONS">Our data from a small cohort study demonstrates that mature neutrophils with a heightened activation phenotype remain in circulation long after initial SARS-CoV-2 infection. Persistent elevation of markers for neutrophil activation and NET formation on LDGs, as well as an enhanced proclivity for platelet-neutrophil aggregation (PNA) formation in COVID-19 convalescent individuals may be associated with PPASC prognosis and development.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Dean, Devendra, Jiyarom, Subia, Tallquist, Nerurkar, Chang, Chow, Shikuma and Park.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>Logan S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devendra</LastName><ForeName>Gehan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Queen's Medical Center, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiyarom</LastName><ForeName>Boonyanudh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subia</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallquist</LastName><ForeName>Michelle D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawai'i at M&#x101;noa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nerurkar</LastName><ForeName>Vivek R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sandra P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Dominic C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikuma</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Juwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hawaii Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI, &#xa0;United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Manoa, Honolulu, HI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI027757</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 HL143960</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL144067</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD007601</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HL156112</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Immunol. 2023 Apr 28;14:1209624. doi: 10.3389/fimmu.2023.1209624</RefSource><PMID Version="1">37187732</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006098" MajorTopicYN="N">Granulocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">low-density granulocyte</Keyword><Keyword MajorTopicYN="N">neutrophil extracellular traps</Keyword><Keyword MajorTopicYN="N">platelet-neutrophil aggregates</Keyword><Keyword MajorTopicYN="N">platelets</Keyword><Keyword MajorTopicYN="N">post-acute sequalae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">pulmonary sequelae</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36591237</ArticleId><ArticleId IdType="pmc">PMC9797994</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1076724</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center . Mortality analyses. (2022).</Citation></Reference><Reference><Citation>Pascarella G, Strumia A, Piliego C, Bruno F, del Buono R, Costa F, et al. . COVID-19 diagnosis and management: a comprehensive review. J Intern Med (2020) 288:192&#x2013;206. doi:&#xa0;10.1111/joim.13091</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13091</ArticleId><ArticleId IdType="pmc">PMC7267177</ArticleId><ArticleId IdType="pubmed">32348588</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (2021) 53:737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung (2021) 199:113&#x2013;9. doi:&#xa0;10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Didangelos A. COVID-19 hyperinflammation: What about neutrophils? mSphere (2020) 5. doi:&#xa0;10.1128/mSphere.00367-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00367-20</ArticleId><ArticleId IdType="pmc">PMC7316488</ArticleId><ArticleId IdType="pubmed">32581077</ArticleId></ArticleIdList></Reference><Reference><Citation>Parackova Z, Zentsova I, Bloomfield M, Vrabcova P, Smetanova J, Klocperk A, et al. . Disharmonic inflammatory signatures in COVID-19: Augmented neutrophils&#x2019; but impaired monocytes&#x2019; and dendritic cells&#x2019; responsiveness. Cells (2020) 9:2206. doi:&#xa0;10.3390/cells9102206</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102206</ArticleId><ArticleId IdType="pmc">PMC7600406</ArticleId><ArticleId IdType="pubmed">33003471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Wang X, Du J, Liu C, Jiang Y, Zhang H, et al. . Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease. Epidemiol Infect (2021) 149:e81. doi:&#xa0;10.1017/S0950268821000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000674</ArticleId><ArticleId IdType="pmc">PMC8027554</ArticleId><ArticleId IdType="pubmed">33775266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Kanthi Y, Knight JS, Kim AHJ. The interplay between neutrophils, complement, and microthrombi in COVID-19. Best Pract Res Clin Rheumatol (2021) 35:101661. doi:&#xa0;10.1016/j.berh.2021.101661</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2021.101661</ArticleId><ArticleId IdType="pmc">PMC7831864</ArticleId><ArticleId IdType="pubmed">33526325</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillon A, Trimaille A, Favre J, Jesel L, Morel O, Kauffenstein G. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. J Thromb Haemost (2022) 20:17&#x2013;31. doi:&#xa0;10.1111/jth.15566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15566</ArticleId><ArticleId IdType="pmc">PMC8646423</ArticleId><ArticleId IdType="pubmed">34672094</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliadi V, Konstantinidou I, Aftzoglou K, Iliadis S, Konstantinidis TG, Tsigalou C. The emerging role of neutrophils in the pathogenesis of thrombosis in COVID-19. Int J Mol Sci (2021) 22:5368. doi:&#xa0;10.3390/ijms22105368</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105368</ArticleId><ArticleId IdType="pmc">PMC8161034</ArticleId><ArticleId IdType="pubmed">34065210</ArticleId></ArticleIdList></Reference><Reference><Citation>Genchi A, Semerano A, Schwarz G, Dell&#x2019;Acqua B, Gullotta GS, Sampaolo M, et al. . Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients. Acta Neuropathol Commun (2022) 10:14. doi:&#xa0;10.1186/s40478-022-01313-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01313-y</ArticleId><ArticleId IdType="pmc">PMC8805426</ArticleId><ArticleId IdType="pubmed">35105380</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermayer A, Jakob LM, Haslbauer JD, Matter MS, Tzankov A, Stoiber W. Neutrophil extracellular traps in fatal COVID-19-Associated lung injury. Dis Markers (2021) 2021. doi:&#xa0;10.1155/2021/5566826</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5566826</ArticleId><ArticleId IdType="pmc">PMC8337148</ArticleId><ArticleId IdType="pubmed">34367376</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenz J, Obermaier M, Uhle S, Weigand MA, Uhle F. Low-density granulocyte contamination from peripheral blood mononuclear cells of patients with sepsis and how to remove it &#x2013; a technical report. Front Immunol (2021) 12:684119. doi:&#xa0;10.3389/fimmu.2021.684119</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.684119</ArticleId><ArticleId IdType="pmc">PMC8416421</ArticleId><ArticleId IdType="pubmed">34484182</ArticleId></ArticleIdList></Reference><Reference><Citation>Seman BG, Robinson CM. The enigma of low-density granulocytes in humans: Complexities in the characterization and function of LDGs during disease. Pathogens (2021) 10:1091. doi:&#xa0;10.3390/pathogens10091091</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10091091</ArticleId><ArticleId IdType="pmc">PMC8470838</ArticleId><ArticleId IdType="pubmed">34578124</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell (2021) 184:1671&#x2013;92. doi:&#xa0;10.1016/j.cell.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante-Silva LHA, Carvalho DCM, Lima EA, Galvao J, da Silva JSF, Sales-Neto JM, et al. . Neutrophils and COVID-19: The road so far. Int Immunopharmacol (2021) 90:107233. doi:&#xa0;10.1016/j.intimp.2020.107233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107233</ArticleId><ArticleId IdType="pmc">PMC7703515</ArticleId><ArticleId IdType="pubmed">33290963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, et al. . A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med (2021) 2:100166. doi:&#xa0;10.1016/j.xcrm.2020.100166</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100166</ArticleId><ArticleId IdType="pmc">PMC7817872</ArticleId><ArticleId IdType="pubmed">33521697</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemi&#x144;ska I, W&#x119;glarczyk K, Surmiak M, Kurowska-Baran D, Sanak M, Siedlar M, et al. . Mild and asymptomatic COVID-19 convalescents present long-term endotype of immunosuppression associated with neutrophil subsets possessing regulatory functions. Front Immunol (2021) 12:748097. doi:&#xa0;10.3389/fimmu.2021.748097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748097</ArticleId><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xia C, Chen J, Fan C, He J. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset still&#x2019;s disease. Rheumatol (United Kingdom) (2021) 60:297&#x2013;303. doi:&#xa0;10.1093/rheumatology/keaa324</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa324</ArticleId><ArticleId IdType="pubmed">32757000</ArticleId></ArticleIdList></Reference><Reference><Citation>Seman BG, Vance JK, Akers SM, Robinson CM. Neonatal low-density granulocytes internalize and kill bacteria but suppress monocyte function using extracellular DNA. J Cell Sci (2021) 134. doi:&#xa0;10.1242/jcs.252528</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.252528</ArticleId><ArticleId IdType="pubmed">33589502</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Ye J, Luo Q, Huang Z, Peng Y, Xiong G, et al. . Low-density granulocytes are elevated in mycobacterial infection and associated with the severity of tuberculosis. PloS One (2016) 11. doi:&#xa0;10.1371/journal.pone.0153567</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153567</ArticleId><ArticleId IdType="pmc">PMC4830625</ArticleId><ArticleId IdType="pubmed">27073889</ArticleId></ArticleIdList></Reference><Reference><Citation>Valcour VG, Shiramizu BT, Shikuma CM. HIV DNA In circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol (2010) 87:621&#x2013;6. doi:&#xa0;10.1189/jlb.0809571</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0809571</ArticleId><ArticleId IdType="pmc">PMC2858306</ArticleId><ArticleId IdType="pubmed">20130221</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitte J, Diallo AB, Boumaza A, Lopez A, Michel M, Allardet-Servent J, et al. . A granulocytic signature identifies COVID-19 and its severity. J Infect Dis (2020) 222:1985&#x2013;96. doi:&#xa0;10.1093/infdis/jiaa591</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa591</ArticleId><ArticleId IdType="pmc">PMC7543529</ArticleId><ArticleId IdType="pubmed">32941618</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkerman R, Bongers SH, Bindels BJJ, Tinnevelt GH, Giustarini G, Jorritsma NKN, et al. . Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation. J Leukoc Biol (2021) 109. doi:&#xa0;10.1002/JLB.5COVA0820-520RRR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0820-520RRR</ArticleId><ArticleId IdType="pmc">PMC10016865</ArticleId><ArticleId IdType="pubmed">33617030</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkerman R, Jorritsma NKN, Bongers SH, Bindels BJJ, Jukema BN, Hesselink L, et al. . An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients. Scand J Immunol (2021) 93:e13023. doi:&#xa0;10.1111/sji.13023</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.13023</ArticleId><ArticleId IdType="pmc">PMC7995011</ArticleId><ArticleId IdType="pubmed">33482019</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, et al. . A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight (2021) 6. doi:&#xa0;10.1172/jci.insight.148435</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148435</ArticleId><ArticleId IdType="pmc">PMC8262329</ArticleId><ArticleId IdType="pubmed">33986193</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. . Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell (2020) 182:1401&#x2013;18. doi:&#xa0;10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Combadiere B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, et al. . LOX-1-Expressing immature neutrophils identify critically-ill COVID-19 patients at risk of thrombotic complications. Front Immunol (2021) 12:752612. doi:&#xa0;10.3389/fimmu.2021.752612</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.752612</ArticleId><ArticleId IdType="pmc">PMC8488276</ArticleId><ArticleId IdType="pubmed">34616409</ArticleId></ArticleIdList></Reference><Reference><Citation>Frishberg A, Kooistra E, Nuesch-Germano M, Pecht T, Milman N, Reusch N, et al. . Mature neutrophils and a NF-kappaB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19. Cell Rep Med (2022) 3:100652. doi:&#xa0;10.1016/j.xcrm.2022.100652</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100652</ArticleId><ArticleId IdType="pmc">PMC9110324</ArticleId><ArticleId IdType="pubmed">35675822</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S, et al. . A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Sci Transl Med (2022) 14:eabo5795. doi:&#xa0;10.1126/scitranslmed.abo5795</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5795</ArticleId><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol (2021) 21:485&#x2013;98. doi:&#xa0;10.1038/s41577-020-00490-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00490-y</ArticleId><ArticleId IdType="pmc">PMC7849958</ArticleId><ArticleId IdType="pubmed">33526920</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, Lesouhaitier M, Gregoire M, Pinceaux K, Gacouin A, Maamar A, et al. . SARS-CoV-2-Induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J Clin Immunol (2021) 41:515&#x2013;25. doi:&#xa0;10.1007/s10875-020-00920-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Ruiz J, Absal&#xf3;n-Aguilar A, Nu&#xf1;ez-Aguirre M, P&#xe9;rez-Fragoso A, Carrillo-V&#xe1;zquez DA, Maravillas-Montero JL, et al. . Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity. Cells (2021) 10:2545. doi:&#xa0;10.3390/cells10102545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102545</ArticleId><ArticleId IdType="pmc">PMC8533917</ArticleId><ArticleId IdType="pubmed">34685525</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res (2017) 5:3&#x2013;8. doi:&#xa0;10.1158/2326-6066.CIR-16-0297</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-16-0297</ArticleId><ArticleId IdType="pmc">PMC5426480</ArticleId><ArticleId IdType="pubmed">28052991</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandau S, Hartl D. Lost in neutrophil heterogeneity? CD10! Blood (2017) 129:1240&#x2013;1. doi:&#xa0;10.1182/blood-2017-01-761585</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-01-761585</ArticleId><ArticleId IdType="pubmed">28280045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Khankhanian P, Salama C, Brown M, Lieber J. Pseudo-Pelger&#x2013;hu&#xeb;t anomaly and granulocytic dysplasia associated with human granulocytic anaplasmosis. Int J Hematol (2015) 102:129&#x2013;33. doi:&#xa0;10.1007/s12185-015-1769-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-015-1769-1</ArticleId><ArticleId IdType="pubmed">25749661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>